Delivery Order SPE2DE24D0013-SPE2D626F6358

Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $5,236 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on October 29, 2025, with an ultimate completion date of November 13, 2025. The contract, designated as XPCOV2/FLU/RSV-10, is for molecular diagnostic testing supplies and reagents, likely including test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. No set-aside designation was applied to this award. The delivery order will be performed at Cepheid's Sunnyvale facility, leveraging the company's established expertise in providing rapid molecular diagnostic solutions to federal healthcare agencies.

This award reflects Cepheid's continued role as a primary federal supplier of diagnostic capabilities to the Department of Defense medical enterprise. As a manufacturer of advanced molecular diagnostic systems and reagents, Cepheid has secured extensive procurement across the Defense Health Agency, Defense Logistics Agency Medical Supply Chain, and other federal health entities. The company's competitive positioning in federal molecular diagnostics procurement is evidenced by its multiple indefinite delivery contracts with the Department of Veterans Affairs, including a $32.8 million vehicle with Veterans Integrated Service Network 6 and a $6.7 million contract with VISN 17, demonstrating the Defense Logistics Agency's confidence in Cepheid's supply chain reliability for critical diagnostic testing solutions.